OTC : EVOTF

Evotec SE

$6.69 USD

$0 (0.0%)

Volume
100
Average Volume
3
Market Capitalization
$1.19B
P/E Ratio
-3.25
Dividend Yield
0.00%
Price Target
Year High
$8.52
Year Low
$4.73
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.68
Company Overview

OTC

Christian Wojczewski

Drug Manufacturers - Specialty & Generic

Healthcare

EVOTF

4766

DE

USD

https://www.evotec.com

49 40 560 81 0

N/A

0001412558

Liquidity Metrics

0.55

1.68

1.60

0.92

0.00

Sales & Valuation

$788.08M

0.84

0.90

-14.81

-0.24

Profitability

-$0.58

-$103.48M

-26.02%

-24.04%

-24.55%

-11.82%

P/E Metrics

-3.25

0.04

0.04

Analyst Price Target & Rating

Strong Sell

1/5

6 Analysts

%

Financial Health Scores

0.27

4/9

$289M

$1.65B

$943.76M

-$141.45M

Key Metrics (TTM)

$631.07M

0.85

-16.35

1.68

-24.55%

-7.93%

-30.71%

-6.71%

70 days

Company Executives
Name Title
Sarah Fakih Executive VP, Head of Global Communications & Investor Relations
Aurelie Dalbiez Chief People Officer & Member of Management Board
Christian Wojczewski CEO & Chairperson of the Management Board
Christian Dargel EVice President Global Head of Legal & Compliance
Ian Hunneyball Senior Vice President of Programme Management & Clinical Operations
David Hallet Executive Vice President
Uwe Andag EVP Head of Metabolic Diseases
Cord Dohrmann Chief Scientific Officer & Member of Management Board
Ingrid Mller Chief Operating Officer & Member of Management Board
Claire Hinshelwood Chief Financial Officer & Member of Management Board
Poll Results

No votes yet today — be the first to share your view!

About Evotec SE (OTC:EVOTF) Stock

Evotec SE serves as a prominent global partner, offering comprehensive drug discovery and development services to both the pharmaceutical and biotechnology sectors worldwide. The company is actively involved in advancing pharmaceutical products across a diverse array of therapeutic areas. These encompass, among others, diabetes and its related complications, fibrosis, infectious diseases, central nervous system (CNS) disorders, oncology, pain and inflammatory conditions, immunology, rare diseases, respiratory ailments, and women's health. Evotec maintains extensive collaboration agreements with numerous leading industry entities, including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang ... JingXin Pharmaceutical Co., Ltd., Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Founded in 1993, the company changed its name from Evotec AG to Evotec SE in April 2019 and is headquartered in Hamburg, Germany.

Evotec Q2 Earnings Call Highlights

2026-07-14 09:03:38

Evotec NASDAQ: EVO reported preliminary unaudited results for the second quarter and first half of 2026 and lowered its full-year outlook, citing delayed strategic partnership revenue, slower conversion of commercial activity into revenue and longer timelines for new partnership agreements.

Frequently Asked Questions

What is the current Evotec SE (EVOTF) stock price?

Evotec SE(OTC:EVOTF) stock price is $6.69 in the last trading session. During the trading session, EVOTF stock reached the peak price of $8.5157 while $4.725 was the lowest point it dropped to. The percentage change in EVOTF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EVOTF stock was $0.

EVOTF's industry and sector of operation?

The OTC listed EVOTF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of EVOTF?

Sarah Fakih | Executive VP, Head of Global Communications & Investor Relations
Aurelie Dalbiez | Chief People Officer & Member of Management Board
Christian Wojczewski | CEO & Chairperson of the Management Board
Christian Dargel | EVice President Global Head of Legal & Compliance
Ian Hunneyball | Senior Vice President of Programme Management & Clinical Operations

How many employees does EVOTF have?

Number of EVOTF employees currently stands at 4766. EVOTF operates from Essener Bogen 7, Hamburg, HA 22419, DE.

Link for EVOTF official website?

Official Website of EVOTF is: https://www.evotec.com

How do I contact EVOTF?

EVOTF could be contacted at phone #49 40 560 81 0 and can also be accessed through its website. EVOTF operates from Essener Bogen 7, Hamburg, HA 22419, DE.

How many shares of EVOTF are traded daily?

The average number of EVOTF shares traded daily for last 3 months was 3.

What is the market cap of EVOTF currently?

The market value of EVOTF currently stands at $1.19B with its latest stock price at $6.69